Advertisement
News
Advertisement

Sorin wins new Euro approvals for Perceval heart valve and accessories

Tue, 09/18/2012 - 4:01pm
Mass Device

Sorin Group wins CE Mark approval extending use of its Perceval bioprosthetic valve and authorizing a new suite of implantation accessories.

Sorin Group logo

Sorin Group (BIT:SRN) touted new European regulatory wins extending use of its Perceval bioprosthetic heart valve and approving a new suite of implantation accessories.  

The Perceval valve, which originally won CE Mark last year, was previously limited to patients aged 75 or older. The new indication lowers the age to 65 for patients with aortic valve stenosis or steno-insufficiency.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading